Fig 2.
Receiver operative characteristic curves of pro-surfactant protein B (pro-SFTPB), N1,N12-diacetylspermine (DAS), and combination of pro-SFTPB and DAS in lung cancer samples collected 0 to 6 months before diagnosis compared with matched controls in the validation set. AUC, area under the curve.